Position in VERU
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$181,540
+$75,460 QoQ
Shares Held
58,000
+20.8% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BLAIR WILLIAM & CO/IL holds $184,064,705 across 61 Biotechnology names. VERU ranks #45 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
513,573 | $36,283,932 | |
| 2 | TWST |
Twist Bioscience Corp
|
256,556 | $26,394,481 | |
| 3 | ARGX |
Argenx SE
|
27,666 | $25,667,684 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
416,766 | $16,258,041 | |
| 5 | EXEL |
Exelixis, Inc.
|
243,215 | $13,233,328 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,400 | $9,139,832 | |
| 7 | SLDB |
Solid Biosciences Inc.
|
756,277 | $7,555,207 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
23,450 | $5,739,856 |
All Filings in VERU
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $181,540 | 58,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $106,080 | 48,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $102,720 | 48,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $144,400 | 38,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $220,400 | 380,000 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $171,500 | 350,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $227,500 | 350,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $269,500 | 350,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $294,000 | 350,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $231,000 | 330,000 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $237,600 | 330,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $237,600 | 330,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $380,800 | 320,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $348,098 | 300,085 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,584,448 | 300,085 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,917,779 | 340,085 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,842,960 | 340,085 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,593,537 | 329,925 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,854,908 | 314,925 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,643,233 | 309,875 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,501,094 | 309,925 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,287,091 | 304,925 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,594,351 | 299,925 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $334,377 | 127,625 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $426,267 | 127,625 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $417,333 | 127,625 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||